about
Identification of quiescent and spatially restricted mammary stem cells that are hormone responsive.Construction of developmental lineage relationships in the mouse mammary gland by single-cell RNA profiling.Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer.Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer.Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancerBarcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancerPublisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancerA Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast CancerDual targeting of CDK4/6 and BCL2 pathways augments tumor response in estrogen receptor positive breast cancerTargeting triple-negative breast cancers with the Smac-mimetic birinapantTissue-resident ductal macrophages survey the mammary epithelium and facilitate tissue remodelling
P50
Q42505597-82D8585A-9609-4715-86F5-9AD54CAC7771Q47321523-29E49DDC-C73A-472B-99DC-0DD95350C2CDQ47741752-6DF6269A-83B2-463D-B533-4FD1045D088BQ48311135-43ADD74B-A371-4AFB-A497-5FBE143DB14AQ61124716-57467B1A-0D92-49FC-AA52-B373A79E3B47Q61795904-378FC2B4-E48F-4110-840D-EB822650A487Q64094908-2E1AB474-A17A-4941-B991-B71518BC1AB8Q90286274-836A8390-63E6-49D6-8947-927E624E4B27Q91554228-316BB5F6-B3B4-4200-8F89-F6A4571ACF57Q93270509-F069B73B-B101-4C67-9B59-29BFB70536D2Q93270876-89E87D7C-1E26-40AD-BACF-7987ED1B2374
P50
description
researcher
@en
wetenschapper
@nl
name
François Vaillant
@en
François Vaillant
@nl
type
label
François Vaillant
@en
François Vaillant
@nl
prefLabel
François Vaillant
@en
François Vaillant
@nl
P31
P496
0000-0003-3229-3760